Modern technology appears to have saved a Soviet relic, following a smartphone vote on the fate of Moscow's extraordinary Shukhov Tower
With the Ebola outbreak in West Africa doubling by the month, the World Health Organization is pushing more extreme measures to contain the virus
More than 40,000 years ago, a Neanderthal scratched a pattern into the floor of a cave in Gibraltar. Is it a doodle, a message or a work of art?
The Oscar-winning actress is one of many celebrities who had nude photos maliciously leaked on the internet last night – but how did it happen?
An idyllic farmhouse, challenging thoughts on conservation, an author who sounds like a great guy. What's not to hate in A Buzz in the Meadow?
Ashya King was removed from a UK hospital so he could get proton beam therapy for his cancer. Two centres will make it more widely available in the UK from 2018
When it comes to cuteness, the otter and puffin are neck and neck, but in a watery duel, the otter wins hands down
All the latest on newscientist.com: verbal autopsies, non-stop global warming from now on, football head injuries, telltale fraud language and more
The "gold bowl of Hasanlu" and three skeletons were excavated from beneath a burned building in an ancient Iranian citadel – now we know the full story
Relatives of the recently deceased are helping to pin down the causes of deaths in India, and boost public health, says epidemiologist Prabhat Jha (full text available to subscribers)
Enjoy the recent slowdown in global warming while it lasts, because it's probably the last one we will get this century
The US Food and Drug Administration (FDA) plans to ensure representation of demographic subgroups (eg, age, ethnic origin, and sex) in clinical trials of drugs and medical products, with an action plan to improve data collection by study funders, identify barriers to subgroup enrolment in trials, and make subgroup data more available.
To coincide with the China Medical Board's 100th anniversary celebratory conference in Beijing, today The Lancet publishes its fifth China theme issue on the future of China's health. This issue examines the rapid transition of China's burden of non-communicable diseases and injuries, health-system reform, and the long term future of the population's health. The success of China's health-care system will depend on an effective workforce that is talent driven and educated in a way that addresses the country's burden of disease.
In the 65 years since independence, China has made good progress in improving population health and moving towards universal health coverage. Life expectancy has improved substantially—from 40 years in 1950 to 76 years in 2011. However, ongoing health challenges include an expanding burden of non-communicable diseases (NCDs), such as cardiovascular disease, chronic obstructive pulmonary disease, lung cancer, and diabetes. NCDs are now China's number one health threat, contributing more than 80% of the country's 10·3 million annual deaths, and nearly 70% of its total disease burden.
A report published by the UK Centre for Health and the Public Interest (CHPI) last week raised concerns about the quality of care in some private hospitals and highlighted the effect on the National Health Service (NHS) of these failings in care. The review describes inadequate reporting, both of patient safety incidents and of hospitals’ performance, preventing proper assessment of risk, problems with staffing, a lax safety culture, and inadequate record-keeping. Clinical governance, widely recognised as essential for the delivery of high quality care, has no statutory basis in private hospitals, and the overseeing committees have no legal duties, no power to enforce good practice, and potential conflicts of interest.
“If science and education are the brain and nervous system of civilization, health is the heart. It is the organ that pushes the vital fluid to every part of the social organism.”
China has increasingly emerged as an important player in global health, especially after the World Bank reclassified China as an upper-middle-income country in 2011. What is China doing for global health? Is China's engagement distinctive or similar to that of other countries? What does the evidence show about China's global health engagement? In this issue of The Lancet, Peilong Liu and coauthors address these questions in a paper on global health with Chinese characteristics.
As one of the most rapidly growing countries and the largest energy consumer in the world, environmental pollution in China, including that of air, water, and land, puts its people at risk of many acute and chronic diseases. In today's global economy, products are manufactured and traded around the world. In the context of this increasing globalisation, measurable amounts of pollutants from China are spreading overseas via both natural and human means, resulting in substantial global health concerns.
China has more older people (65 years and older) than any other country. According to the 2010 census, the number of people aged 65 years and older was 119 million, 8·9% of the population. Moreover, China's population is one of the fastest ageing in the world. Although developed countries took around half a century to double the number of people aged 65 years and older (from 7% to 14%), China will do so in half that time. By 2050, China's ageing population will match that of many of today's developed countries—and exceed that of countries such as Denmark, New Zealand, Australia, and the USA.
The early detection of life-threatening, critical congenital heart defects in newborn babies still presents an important clinical challenge. Most defects are amenable to intervention but timely diagnosis (ie, before presentation with cardiovascular collapse or death) is crucial. In high-income countries, examination and, increasingly, antenatal ultrasound have formed the basis of screening, but test accuracy of these procedures is variable and many babies with critical congenital heart defects are discharged before diagnosis.